References
- First Author. Are proton pump inhibitors suitable medicines to prevent gastrointestinal events due to non-steroidal anti-inflammatory drugs? J Pharm Pract. 2018;1:5.
- Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014;34:771–785.
- Scarpignato C, Gatta L, Zullo A, et al. Italian society of pharmacology, the Italian association of hospital gastroenterologists, and the Italian federation of general practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases – a position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179–214.
- Savarino V, Dulbecco P, de Bortoli N, et al. The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal. Eur J Intern Med. 2017;37:19–24.
- Savarino V, Tosetti C, Benedetto E, et al. Appropriateness in prescribing PPIs: A position paper of the Italian society of gastroenterology (SIGE) – study section “digestive diseases in primary care”. Dig Liver Dis. 2018;50:894–902.
- Bjarnason I, Scarpignato C, Holmgren E, et al. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154:500–514.
- Savarino V, Marabotto E, Zentilin P, et al. Proton pump inhibitors: use and misuse in the clinical setting. Exp Rev Clin Pharmacol. 2018;11:1123–1134.
- Tai FWD, McAlindon ME. NSAIDS and the small bowel. Curr Opin Gastroenterol. 2018;34:175–182.
- Savarino V, Dulbecco P, Savarino E. Are proton pump inhibitors really so dangerous? Dig Liver Dis. 2016;48:851–859.
- Shubert ML. Adverse effects of proton pump inhibitors: fact or fake news? Curr Opin Gastroenterol. 2018;34:451–457.
- Savarino E, Marabotto E, Zentilin P, et al. A safety review of proton pump inhibitors to treat acid-related digestive diseases. Expert Opin Drug Saf. 2018;17:785–794.
- Freedberg DE, Kim LS, Yang X-Y. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advise from the American gastroenterological association. Gastroenterology. 2017;152:706–715.
- Targownik L. Discontinuing long-term PPI therapy: why, with whom and how? Am J Gastroenterol. 2018;113:519–528.
- Zhang S, Qing Q, Bai Y, et al. Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and neta-analysis. Dig Dis Sci. 2013;58:1991–2000.